ANTONIO
CASADO HERRÁEZ
Profesor asociado
University of Milano-Bicocca
Milán, ItaliaPublicaciones en colaboración con investigadores/as de University of Milano-Bicocca (4)
2022
-
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study
Gynecologic Oncology, Vol. 165, Núm. 1, pp. 40-48
2017
-
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 18, Núm. 9, pp. 1274-1284
2016
-
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
Annals of Oncology, Vol. 27, Núm. 1, pp. 16-41
2014
-
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study
Journal of Clinical Oncology, Vol. 32, Núm. 4, pp. 320-326